Overview
Status
Active
Registry date
2023-03-24
Share capital
6,000.00 PLN
Registered address
ul. Owocowa 10A, 40-133 Katowice, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Daniel Rzepka – Management Board Member
Magdalena Teresa Kanclerz – President of the Management Board
Tomasz Roman Kowalski – Attorney-in-fact (joint)
Manner of representation
The company is represented by two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Magdalena Teresa Kanclerzage 45 | 40 | $540.25 | 33.3333% |
Tomasz Roman Kowalskiage 41 | 40 | $540.25 | 33.3333% |
Daniel Rzepkaage 43 | 40 | $540.25 | 33.3333% |
Beneficial owners
No beneficial owners recorded for the company Med4cana.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 20, 2026 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o. | $1,592,037.83 | sulphur.com.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-08-03 | Liquidation opened | |
| 2023-03-24 | Entered in the register |
FAQ
The main business activity of Med4cana focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on March 24, 2023.
The headquarters is located at: ul. Owocowa 10A, 40-133 Katowice.
The management board includes Daniel Rzepka (Member of the Management Board).
The share capital of the company is PLN 6,000 (approx. $1,621).
Last updated: 2026-08-03